North China Pharmaceutical Company.Ltd (SHA:600812)

China flag China · Delayed Price · Currency is CNY
4.590
+0.080 (1.77%)
Jul 3, 2026, 3:00 PM CST
Market Cap7.88B -24.5%
Revenue (ttm)8.82B -10.8%
Net Income161.04M -3.2%
EPS0.09 -2.3%
Shares Out 1.72B
PE Ratio48.75
Forward PEn/a
Dividend0.04 (0.76%)
Ex-Dividend DateJun 11, 2026
Volume20,442,246
Open4.530
Previous Close4.510
Day's Range4.490 - 4.620
52-Week Range4.110 - 7.460
Beta0.25
Analystsn/a
Price Targetn/a
Earnings DateAug 22, 2026

About SHA:600812

North China Pharmaceutical Company.Ltd engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company primarily offers anti-infective, biotechnology, and cardiovascular cerebrovascular drugs; and immunomodulators, vitamins, and health products. It also provides chemical, biological, agricultural, and biopharmaceuticals and veterinary drugs. It serves pharmaceutical distributors, agents, hospitals, chain pharmacies, and end-user clinics. North China Pharmaceutical Company.Ltd wa... [Read more]

Sector Healthcare
Founded 1992
Employees 9,972
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600812
Full Company Profile

Financial Performance

In 2025, SHA:600812's revenue was 9.24 billion, a decrease of -6.36% compared to the previous year's 9.87 billion. Earnings were 183.06 million, an increase of 44.15%.

Financial Statements